Breast cancer transcriptome acquires a myriad of regulation changes and splicing is critical for the cell to “tailor-make” specific functional transcripts. We systematically revealed splicing signatures of the three most common types of breast tumors using RNA sequencing: TNBC, non-TNBC and HER2-positive breast cancer. We discovered subtype specific differentially spliced genes and splice isoforms not previously recognized in human transcriptome. Further, we showed that exon skip and intron retention are predominant splice events in breast cancer. In addition, we found that differential expression of primary transcripts and promoter switching are significantly deregulated in breast cancer compared to normal breast. We validated the presence of novel hybrid isoforms of critical molecules like CDK4, LARP1, ADD3 and PHLPP2. Our study provides the first comprehensive portrait of transcriptional and splicing signatures specific to breast cancer sub-types, as well as previously unknown transcripts that prompt the need for complete annotation of tissue and disease specific transcriptome.
RNA sequencing of cancer reveals novel splicing alterations
J. Eswaran,A. Horvath,Sucheta Godbole,Sirigiri Divijendra Natha Reddy,P. Mudvari,K. Ohshiro,D. Cyanam,S. Nair,S. Fuqua,K. Polyak,L. Florea,Rakesh Kumar
Published 2013 in Scientific Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Scientific Reports
- Publication date
2013-04-22
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-56 of 56 references · Page 1 of 1